Database

CARLINA Technologies

Solution provided
Technology
Supplier identity
General description

CARLINA Technologies is a biopharmaceutical company specialized in the development of micro and nanomedicines utilizing innovative drug delivery technologies.

The company develops improved pharmaceutical versions of first generation drugs, or drug candidates under development, in order to increase their efficacy and safety profiles.

Type of Supplier
Biotechnology R&D Company - Diagnostics / Devices and Diagnostics ServicesBiotechnology Company - Therapeutics
Region
Regions of Pays de la Loire, Centre and Poitou-Charentes, FR
Regional access broker
  • Grégory Bauer, Atlanpole Biotherapies
Activity description
The 3 top equipments available

While developing its proprietary micro and nanomedicines, CARLINA Technologies also provides high quality R&D formulation development services to the pharmaceutical, biotechnology and veterinary industries including:

•Pre-formulation
•Formulation
•Process manufacturing
•Preclinical batch production
•Scale-up and technology transfer
•Analytical method development
•Stability studies
If your drug candidate requires improved solubilization, stability, protection, pharmacokinetics, bioavailability, targeting, controlled delivery, safety, whatever the administration route used, CARLINA Technologies will help you to design, develop and manufacture the most unique and appropriate delivery system according to the nature of your active ingredient without affecting its chemical integrity.

Thanks to the outstanding know-how of its R&D team, CARLINA technologies can use all available proprietary, as well as off-patent, drug delivery systems including:

•SOLUDOTS*
•PEPTIDOTS*
•Liposomes
•Micelles
•Microspheres
•Micro & nanoemulsions
•…

Training and Staff possibilities
No
Contact information
Name
MEYER
Surname
Olivier
Function
CEO
Phone number
+33 (0)2 41 24 92 82
Address
22 rue Roger Amsler
Pépinière Amsler biotech 2
49100  Angers
France